Literature DB >> 26468108

A Murine Model for Escherichia coli Urinary Tract Infection.

Thomas J Hannan1, David A Hunstad2,3.   

Abstract

Urinary tract infections (UTI) are among the most common bacterial infections of humans. The mouse provides an excellent and tractable model system for cystitis and pyelonephritis caused by Escherichia coli and other uropathogens. Using a well-established model of experimental cystitis in which the bladders of female mice are infected via transurethral catheterization, the molecular details of the pathogenesis of bacterial cystitis have been substantially illuminated in the last decade. Uropathogenic E. coli attach to bladder epithelium (both in human and mouse) via adhesive type 1 pili, establish a replicative niche within epithelial cell cytoplasm, and form intracellular bacterial communities that are protected from antibiotic effects and immune clearance. The use of different inbred and mutant mouse strains offers the opportunity to study outcomes of infection, including resolution, formation of quiescent intracellular bacterial reservoirs, chronic bacterial cystitis, and recurrent infections. Urine, bladder, and kidney tissues can be analyzed by bacterial culture, histology, immunohistochemistry, immunofluorescent and confocal microscopy, electron microscopy, and flow cytometry, while a broad array of soluble markers (e.g., cytokines) can also be profiled in serum, urine, and tissue homogenates by ELISA, Western blotting, multiplex bead array, and other approaches. This model promises to afford continued opportunity for discovery of pathogenic mechanisms and evaluation of therapeutic and preventive strategies for acute, chronic, and recurrent UTI.

Entities:  

Keywords:  Bacterial persistence; Cystitis; Escherichia coli; Intracellular bacterial community; Urinary tract infection

Mesh:

Year:  2016        PMID: 26468108      PMCID: PMC4624421          DOI: 10.1007/978-1-4939-2854-5_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  67 in total

1.  Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function.

Authors:  Jon M Davis; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.

Authors:  Jon M Davis; Humberto M Carvalho; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.

Authors:  Danelle S Eto; Jamie L Sundsbak; Matthew A Mulvey
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

4.  Urologic diseases in America Project: analytical methods and principal findings.

Authors:  Mark S Litwin; Christopher S Saigal; Elizabeth M Yano; Chantal Avila; Sandy A Geschwind; Jan M Hanley; Geoffrey F Joyce; Rodger Madison; Jennifer Pace; Suzanne M Polich; Mingming Wang
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

5.  Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium.

Authors:  D A Eschenbach; D L Patton; T M Hooton; A S Meier; A Stapleton; J Aura; K Agnew
Journal:  J Infect Dis       Date:  2001-02-21       Impact factor: 5.226

6.  Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection.

Authors:  T P Flanigan; J W Hogan; D Smith; E Schoenbaum; D Vlahov; P Schuman; K Mayer
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

7.  Risk factors for recurrent urinary tract infection in young women.

Authors:  D Scholes; T M Hooton; P L Roberts; A E Stapleton; K Gupta; W E Stamm
Journal:  J Infect Dis       Date:  2000-08-31       Impact factor: 5.226

8.  Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.

Authors:  J D Schilling; M A Mulvey; C D Vincent; R G Lorenz; S J Hultgren
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

9.  Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice; Chia S Hung; Scott R Lauer; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 10.  Catheter-related urinary tract infection.

Authors:  Lindsay E Nicolle
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

View more
  21 in total

1.  Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.

Authors:  Valerie P O'Brien; Matthew S Joens; Amanda L Lewis; Nicole M Gilbert
Journal:  J Vis Exp       Date:  2020-12-04       Impact factor: 1.355

2.  Sex Differences in Population Dynamics during Formation of Kidney Bacterial Communities by Uropathogenic Escherichia coli.

Authors:  Lisa K McLellan; Allyssa L Daugherty; David A Hunstad
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

3.  Bladder infection with uropathogenic Escherichia coli increases the excitability of afferent neurons.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Sheldon I Bastacky; Dennis R Clayton; Wily G Ruiz; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-15

4.  Genetic diversity and virulence characteristics of biofilm-producing uropathogenic Escherichia coli.

Authors:  Ali Qasemi; Fateh Rahimi; Mohammad Katouli
Journal:  Int Microbiol       Date:  2021-10-27       Impact factor: 2.479

5.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Escherichia coli in dogs and cats, horses, swine, poultry, cattle, sheep and goats.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Francesca Baldinelli; Alessandro Broglia; Lisa Kohnle; Julio Alvarez
Journal:  EFSA J       Date:  2022-05-10

Review 6.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

Review 7.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

8.  Androgen exposure potentiates formation of intratubular communities and renal abscesses by Escherichia coli.

Authors:  Patrick D Olson; Lisa K McLellan; Teri N Hreha; Alice Liu; Kelleigh E Briden; Keith A Hruska; David A Hunstad
Journal:  Kidney Int       Date:  2018-07-03       Impact factor: 10.612

9.  Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.

Authors:  Víctor M Luna-Pineda; Juan Pablo Reyes-Grajeda; Ariadnna Cruz-Córdova; Zeus Saldaña-Ahuactzi; Sara A Ochoa; Carmen Maldonado-Bernal; Vicenta Cázares-Domínguez; Leticia Moreno-Fierros; José Arellano-Galindo; Rigoberto Hernández-Castro; Juan Xicohtencatl-Cortes
Journal:  Front Cell Infect Microbiol       Date:  2016-10-31       Impact factor: 5.293

10.  Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine.

Authors:  Qiao Su; Tianbing Guan; Haitao Lv
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.